Advertisement

Topics

Biosimilar sales remain small in 'largely untapped' market

12:33 EDT 13 Jun 2018 | BioPharma-Reporter

Many unanswered questions surrounding the nascent biosimilar market are creating challenges â though less regulated markets may benefit from 'less well defined' definitions, says analyst.

Original Article: Biosimilar sales remain small in 'largely untapped' market

NEXT ARTICLE

More From BioPortfolio on "Biosimilar sales remain small in 'largely untapped' market"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...